We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFUN
326
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $4.01M | 0.05% |
12,150
+5,851
| +93% | +$1.9M |
|
|
CALD
327
DELISTED
Callidus Software, Inc.
CALD
| $3.99M | 0.05% |
+235,000
| New | +$3.77M |
|
|
EE
328
DELISTED
El Paso Electric Company
EE
| $3.94M | 0.05% |
107,000
+15,703
| +17% | +$563K |
|
|
ARGO
329
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $3.9M | 0.05% |
87,152
-124
| -0.1% | -$5.51K |
|
|
VTLE
330
DELISTED
Vital Energy
VTLE
| $3.9M | 0.05% |
20,669
-4,648
| -18% | -$919K |
|
|
FOE
331
DELISTED
Ferro Corporation
FOE
| $3.88M | 0.05% |
354,670
-220,860
| -38% | -$2.99M |
|
|
RKUS
332
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $3.86M | 0.05% |
+325,000
| New | +$3.65M |
|
|
HNT
333
DELISTED
HEALTH NET INC
HNT
| $3.84M | 0.05% |
+63,745
| New | +$4.22M |
|
334
Crown Castle
CCI
$33.3B
| $3.77M | 0.05% |
47,842
-13,548
| -22% | -$1.1M |
|
335
Arch Capital
ACGL
$34.3B
| $3.77M | 0.05% |
+154,002
| New | +$3.61M |
|
|
NRF
336
DELISTED
NorthStar Realty Finance Corp.
NRF
| $3.75M | 0.05% |
151,807
-232,257
| -60% | -$6.91M |
|
|
ALJ
337
DELISTED
Alon USA Energy Inc
ALJ
| $3.73M | 0.05% |
206,129
-491,215
| -70% | -$9.31M |
|
|
DISH
338
DELISTED
DISH Network Corp.
DISH
| $3.69M | 0.05% |
63,289
-232,823
| -79% | -$14.8M |
|
|
WR
339
DELISTED
Westar Energy Inc
WR
| $3.66M | 0.05% |
+95,279
| New | +$3.52M |
|
340
Antero Resources
AR
$11.1B
| $3.65M | 0.05% |
+172,468
| New | +$4.59M |
|
341
Gold Fields
GFI
$29B
| $3.64M | 0.05% |
1,367,331
-476,427
| -26% | -$1.36M |
|
342
Xenon Pharmaceuticals
XENE
$6.06B
| $3.63M | 0.05% |
440,000
-10,000
| -2% | -$99.3K |
|
343
Cognizant
CTSH
$24.9B
| $3.58M | 0.05% |
+57,155
| New | +$3.59M |
|
344
CALL
Edwards Lifesciences
EW
$49.6B
| $3.55M | 0.05% |
+150,000
| New | +$3.62M |
|
|
PNK
345
DELISTED
Pinnacle Entertainment Inc.
PNK
| $3.51M | 0.05% |
103,565
-113,322
| -52% | -$4.29M |
|
346
Sinclair Inc
SBGI
$992M
| $3.49M | 0.05% |
+138,000
| New | +$3.8M |
|
347
Roper Technologies
ROP
$38.8B
| $3.47M | 0.05% |
22,157
-33
| -0.1% | -$5.45K |
|
348
Dycom Industries
DY
$12B
| $3.46M | 0.05% |
47,800
-53,600
| -53% | -$3.71M |
|
349
Magnachip Semiconductor
MX
$119M
| $3.44M | 0.05% |
521,440
+30,098
| +6% | +$249K |
|
350
TechnipFMC
FTI
$28.1B
| $3.41M | 0.05% |
147,856
+137,896
| +1,384% | +$3.47M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.